Ohio Cancer Research Announces New Executive Director

Wednesday, May 1, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Bill Boggess is named as Ohio Cancer Research's new Executive Director after Thomas Lamb announced his retirement as Executive Director.

COLUMBUS, Ohio, April 30, 2019 /PRNewswire-PRWeb/ -- Ohio Cancer Research (OCR) – an independent nonprofit organization

dedicated to the cure and prevention of the many forms of cancer through aggressive basic seed money research – is pleased to announce the appointment of Bill Boggess as executive director.

Thomas Lamb, former OCR executive director, announced his retirement from the organization this month. Bill Boggess previously served as OCR's associate executive director from 2014 until April 1, 2019 when he was officially named executive director by OCR's board of trustees.

A Columbus, Ohio native, Boggess brings several years of nonprofit leadership and volunteering to the position as well as years of cultivated relationships with community partners, corporate and individual donors, and regional media outlets. Prior to joining OCR in 2001, Boggess was a reporter for a number of Central Ohio newspapers and an advertising director at the Columbus Guardian and CM Media. He received his bachelor's degree in journalism from The Ohio State University.

"Bill has already proven himself an invaluable asset to Ohio Cancer Research, helping the organization achieve significant growth by attracting new donors and broadening OCR's awareness through public events," said OCR board president Deborah Parris, Ph.D. "We are confident that as the face of OCR Bill will continue to work with the local community and our partners to successfully deliver on our mission to improve the lives of those affected by cancer," Parris added.

Nearly $8 million in seed money has been provided to cancer researchers by Ohio Cancer Research, which has, in turn, generated more than $245 million in new money from other sources to continue basic cancer research on projects initially funded by OCR.

Individual cancer researchers have been or are being funded by Ohio Cancer Research at Case Western Reserve University, The Cleveland Clinic, University Hospitals of Cleveland, MetroHealth Medical Center in Cleveland, The Ohio State University, Nationwide Children's Hospital in Columbus, Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of Toledo, Bowling Green State University, Ohio University, University of Dayton, Wright State University, and the former Hipple Cancer Research Center in Dayton.

For additional information regarding Ohio Cancer Research, please call (614) 224-1127.

About Ohio Cancer Research: Ohio Cancer Research (OCR) is an independent statewide, nonprofit organization dedicated to the cure and prevention of the many forms of cancer and the reduction of its debilitating effects through aggressive seed money research, cancer information and awareness. Ohio Cancer Research is not affiliated with any organization and is recognized as a 501(c)(3) organization. For more information about Ohio Cancer Research, visit http://www.ohiocancer.org

 

SOURCE Ohio Cancer Research



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store